Enterprise Value
-15.88M
Cash
29.62M
Avg Qtr Burn
-3.455M
Short % of Float
0.22%
Insider Ownership
23.65%
Institutional Own.
13.57%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MDNA55 (Bizaxofusp) Details Glioblastoma, Cancer | Phase 2b Update | |
MDNA11 (IL-2) Details Cancer, Cold tumors | Phase 2 Data readout |